nominally significantP < 0.05
There are a total of 74 splicing sites were found to have associations with prostate cancer at the nominally significant level threshold (P < 0.05) with P-HEIDI > 0.01 in the Qi et al. cohort and 14 splicing sites in the GTEx V8 cohort.